Carolina Aguilar is CEO and Co-Founder of INBRAIN Neuroelectronics, a BCI therapeutics company pioneering real time precision neurology through the development of high density graphene brain interfaces with unparalleled decoding resolution and micrometric precision modulation with the mission to decode neural signals to improve people’s lives
She has over 20 years of expertise in healthcare out of which she was 13 years in the European Headquarters of Medtronic in Switzerland, leading globally businesses in brain modulation and diabetes where she managed complex markets and large teams that generated high YoY growth and innovation. Carolina is passionate about creating solutions that improve the outcomes that matter to patients and drive healthcare sustainability. Her leadership in Diabetes at the Diabeter clinics contributed to the creation of a Harvard Business School Case at Medtronic. Just recently INBRAIN got FDA breakthrough designation for their innovative neural platform and delivered the world's first application of a graphene-based neural interface in humans. The company also won the Most Innovative Company of the Year in 2022 and the Norrsken IMPACT 100 award in 2024.